Despite strong evidence linking paraquat to Parkinson’s disease, the herbicide is still legal in the U.S., although some states…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Women with Parkinson’s disease have more uneven and unstable muscle contraction than men, even when their clinical symptoms are…
A smartphone app allowing Parkinson’s disease patients to report their day-to-day symptoms is a reliable tool for improving communication with…
Spinal cord stimulation appears to be safe and may help people with Parkinson’s disease maintain movement, although it did…
The University of Southern California’s Keck School of Medicine is recruiting patients for a Phase 1 clinical trial evaluating RNDP-001,…
Small particles called exosomes may help deliver curcumin directly to dopamine-producing nerve cells damaged in Parkinson’s disease, a study…
In the Netherlands, new cases of Parkinson’s disease occur more often in men, older adults, people with higher socioeconomic…
Mair Therapeutics is collaborating with Radboud University in the Netherlands to advance Parkinson’s disease research by developing small molecules…
Low muscle mass is more common in people with mild to moderate Parkinson’s disease than in those without the…
Aerobic exercise may help alleviate motor symptoms and reduce anxiety in early Parkinson’s disease, but there’s a chance…